Sort   by:  
 Page size 
UnknownDedicated mobile application for drug adverse reaction reporting by patients with relapsing remitting multiple sclerosis (Vigip-SEP study): study protocol for a randomized controlled trial.
Not available
S-EPMC5845183 | biostudies-literature
UnknownRisk and Cost Associated With Drug-Drug Interactions Among Aging HIV Patients Receiving Combined Antiretroviral Therapy in France.
Not available
S-EPMC6440683 | biostudies-literature
UnknownSafety and efficacy of apixaban versus warfarin in peritoneal dialysis patients with non-valvular atrial fibrillation: protocol for a prospective, randomised, open-label, blinded endpoint trial (APIDP2).
Not available
S-EPMC11535701 | biostudies-literature
UnknownAssociation Between Disease-Modifying Therapies Prescribed to Persons with Multiple Sclerosis and Cancer: a WHO Pharmacovigilance Database Analysis.
Not available
S-EPMC8608969 | biostudies-literature
UnknownReal versus sham proximal biofield therapy in the treatment of warts of the hands and feet in adults: study protocol for a randomized controlled trial (MAGNETIK study).
Not available
S-EPMC5463300 | biostudies-literature
UnknownIntravenous versus subcutaneous route pharmacokinetics of paracetamol (acetaminophen) in palliative care patients: study protocol for a randomized trial (ParaSCIVPallia).
Not available
S-EPMC6998185 | biostudies-literature
UnknownEffect of peritoneal dialysis in end-stage renal disease on apixaban pharmacokinetics.
Not available
S-EPMC10387390 | biostudies-literature
UnknownBioavailability of dissolved and crushed single tablets of bictegravir, emtricitabine, tenofovir alafenamide in healthy adults: the SOLUBIC randomized crossover study.
Not available
S-EPMC9780524 | biostudies-literature
UnknownEffect of Tenofovir Disoproxil Fumarate and Emtricitabine on nasopharyngeal SARS-CoV-2 viral load burden amongst outpatients with COVID-19: A pilot, randomized, open-label phase 2 trial.
Not available
S-EPMC8235994 | biostudies-literature
UnknownSorafenib in metastatic uveal melanoma: efficacy, toxicity and health-related quality of life in a multicentre phase II study.
Not available
S-EPMC4931363 | biostudies-literature
Sort   by:  
 Page size